Form4insider filings, from the source

SEC Form 4 · accession 0001055726-18-000002

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 7:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 5, 2018M13,333—A2,178,533D
Common StockMar 5, 2018F3,711$4.29D2,174,822D
Common Stockholding———1,750,000IBy Family Limited Partnership
Common Stockholding———33,563IBy Daughter: EK
Common Stockholding———33,775IBy Son: JK1
Common Stockholding———5,975IBy Spouse
Common Stockholding———33,533IBy Son: JK2

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 5, 2018M13,333D——Common Stock13,3330D
Common Stock OptionF3$4.29Mar 5, 2018A138,250AMar 5, 2018Mar 5, 2028Common Stock138,250138,250D
Restricted Stock UnitF4—Mar 5, 2018A360,300A——Common Stock360,300360,300D

Explanation of responses